(Q38614221)

4 September 2017

1 reference

title

Thrombolysis in the management of acute myocardial infarction and unstable angina pectoris (English)

1 reference

acute myocardial infarction

4 September 2017

1 reference

1 reference

1 reference

Loscalzo J

1

1 reference

4 September 2017

1 February 1989

1 reference

4 September 2017

1 reference

4 September 2017

37

1 reference

4 September 2017

2

1 reference

4 September 2017

191-204

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198937020-00006

4 September 2017

0 references

cites work

Coronary angioscopy in patients with unstable angina pectoris

1 reference

12 December 2020

Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.

1 reference

12 December 2020

Influence of alpha 2-plasmin inhibitor on adsorption of plasminogen to fibrin

1 reference

12 December 2020

Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin

1 reference

12 December 2020

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

1 reference

12 December 2020

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

12 December 2020

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

1 reference

12 December 2020

PGE1 accelerates thrombolysis by tissue plasminogen activator

1 reference

12 December 2020

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

1 reference

12 December 2020

Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay

1 reference

12 December 2020

Proceedings: I-Labelled fibrinogen, autoradiography, and stereoarteriography in identification of coronary thrombotic occlusion in fatal myocardial infarction

1 reference

12 December 2020

Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction

1 reference

12 December 2020

Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator

1 reference

12 December 2020

Coronary arteriographic findings soon after non-Q-wave myocardial infarction

1 reference

12 December 2020

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

1 reference

12 December 2020

Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarction

1 reference

12 December 2020

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death

1 reference

12 December 2020

Urokinase Inhibitor in Human Placenta

1 reference

12 December 2020

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

12 December 2020

Plasmin inhibition of platelet function and of arachidonic acid metabolism

1 reference

12 December 2020

Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen

1 reference

12 December 2020

Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate

1 reference

12 December 2020

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

12 December 2020

The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

12 December 2020

Synergism of thrombolytic agents in vivo

1 reference

12 December 2020

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

12 December 2020

Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells

1 reference

12 December 2020

A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction

1 reference

12 December 2020

Autonomous functions of structural domains on human tissue-type plasminogen activator

1 reference

12 December 2020

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

1 reference

12 December 2020

Tissue plasminogen activator promotes platelet disaggregation in plasma

1 reference

12 December 2020

Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator

1 reference

12 December 2020

A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris

1 reference

12 December 2020

Relation of effectiveness of intracoronary thrombolysis in acute myocardial infarction to systemic thrombolytic state

1 reference

12 December 2020

Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine

1 reference

12 December 2020

Intramuscular administration of human tissue-type plasminogen activator in rabbits and dogs and its implications for coronary thrombolysis

1 reference

12 December 2020

Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.

1 reference

12 December 2020

Kinetic mechanism of the activation of human plasminogen by streptokinase

1 reference

12 December 2020

Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy

1 reference

12 December 2020

Coronary thrombolysis with recombinant tissue-type plasminogen activator: patency rate and regional wall motion after 3 months

1 reference

12 December 2020

Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function

1 reference

12 December 2020

A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo

1 reference

12 December 2020

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

1 reference

12 December 2020

Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials

1 reference

12 December 2020

Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction

1 reference

12 December 2020

Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158

1 reference

12 December 2020

Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis

1 reference

12 December 2020

Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator

1 reference

12 December 2020

Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase

1 reference

12 December 2020

Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis

1 reference

12 December 2020

Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction

1 reference

12 December 2020

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

12 December 2020

Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture

1 reference

12 December 2020

Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction

1 reference

12 December 2020

Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1

1 reference

12 December 2020

Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

1 reference

12 December 2020

Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions

1 reference

12 December 2020

Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators

1 reference

12 December 2020

Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion

1 reference

12 December 2020

Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent

1 reference

12 December 2020

Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein

1 reference

12 December 2020

Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction

1 reference

12 December 2020

Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction

1 reference

12 December 2020

Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex

1 reference

12 December 2020

Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species

1 reference

12 December 2020

A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty

1 reference

12 December 2020

Cerebrovascular complications of streptokinase infusion

1 reference

12 December 2020

Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction

1 reference

12 December 2020

Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial

1 reference

12 December 2020

10.2165/00003495-198937020-00006

Identifiers

DOI

1 reference

PubMed ID

2649355

Dimensions Publication ID

4 September 2017

0 references

1 reference

PubMed ID

2649355